课题基金 / 基金详情

TOPIC #411 - PHASE I SBIR CONTRACT - AN IMAGEDX BASED PLATFORM FOR COMPREHENSIVE DE-IDENTIFICATION OF WSI DATA

TOPIC #411 - PHASE I SBIR CONTRACT - AN IMAGEDX BASED PLATFORM FOR COMPREHENSIVE DE-IDENTIFICATION OF WSI DATA
话题
批准号:
10274084
负责人:
CASEY LARIS
金额:
$37.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-16 至 2021-06-15

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该提议的目标是开发一种能够确保整个载玻片成像的粘附性的去识别工具 (WSI)来自多个供应商的数据到HIPAA隐私规则。这样的消除身份工具将被更有效地使用 并全面取消识别商业和政府资助的研究人员所需的大型数据存储。去身份识别 将作为ImageDx去ID模块开发,扩展了目前的Increen Biosciences产品组合 商业ImageDx模块提供全面的计算病理服务。以下目标将是 使用我们的设计驱动开发流程完成:(1)环境分析-确定供应商、文件类型和PHI 字段;(2)识别并提供数据集--从现有未识别的幻灯片、幻灯片标签机和内部提供的数据集 扫描仪;(3)识别、打开、显示和更改WSI文件-开发概念验证De-ID接口,能够 打开和更改跨多个供应商的WSI文件中的PHI信息;以及(3)确定以下项目的数据集和文件类型 第二阶段。项目交付成果的结束是能够识别、打开、显示和 更改来自多个WSI扫描仪供应商的PHI字段。
英文摘要
The objective of this proposal is to develop a de-identification tool capable of ensuring adherence of whole slide imaging (WSI) data from multiple vendors to the HIPAA Privacy Rule. Such a de-identification tool will be used to more efficiently and comprehensively de-identify the large data stores required by commercial and government funded researchers. Deidentification will be developed as the ImageDx De-ID module, extending the current Reveal Biosciences portfolio of commercial ImageDx modules providing comprehensive computation pathology services. The following Aims will be completed using our Design Driven Development process: (1) Landscape analysis – to identify vendors, filetypes, and PHI fields; (2) Identify and provide data sets – datasets provided from existing de-identified slides, slide labelers, and inhouse scanners; (3) Recognize, open, display, and alter WSI files – develop proof of concept De-ID interface capable of opening and altering PHI information in WSI files across multiple vendors; and (3) Identify data sets and file types for Phase II. The end of project deliverable is an ImageDx De-ID module capable of recognizing, opening, displaying, and altering PHI fields from multiple WSI scanner vendors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金